Publications by authors named "S A Seely"

During stress conditions such as heat shock and antibiotic exposure, ribosomes stall on messenger RNAs, leading to inhibition of protein synthesis. To remobilize ribosomes, bacteria use rescue factors such as HflXr, a homolog of the conserved housekeeping GTPase HflX that catalyzes the dissociation of translationally inactive ribosomes into individual subunits. Here we use time-resolved cryo-electron microscopy to elucidate the mechanism of ribosome recycling by Listeria monocytogenes HflXr.

View Article and Find Full Text PDF

Objective: Assess turnaround time (TAT) and cost-benefit of on-site screening and its impact on length of stay (LOS) and costs compared to reference laboratories.

Design: Before-and-after retrospective cohort study.

Setting: Large-tertiary medical center.

View Article and Find Full Text PDF
Article Synopsis
  • * A new point-of-care HPV molecular test was developed, which can identify 14 high-risk HPV types within 30 minutes, making it easier for minimally trained staff to perform the tests.
  • * The test showed high sensitivity of 93% and specificity of 73% compared to traditional methods; an even simpler version achieved 96% sensitivity and 83% specificity, making it suitable for near-patient screenings with follow-up from healthcare professionals.
View Article and Find Full Text PDF

Aminoglycosides are a class of antibiotics that bind to ribosomal RNA and exert pleiotropic effects on ribosome function. Amikacin, the semisynthetic derivative of kanamycin, is commonly used for treating severe infections with multidrug-resistant, aerobic Gram-negative bacteria. Amikacin carries the 4-amino-2-hydroxy butyrate (AHB) moiety at the N amino group of the central 2-deoxystreptamine (2-DOS) ring, which may confer amikacin a unique ribosome inhibition profile.

View Article and Find Full Text PDF

Rapid on-site diagnosis of emerging pathogens is key for early identification of infected individuals and for prevention of further spreading in a population. Currently available molecular diagnostic tests are instrument-based whereas rapid antibody and antigen tests are often not sufficiently sensitive for detection in pre-symptomatic subjects. There is a need for rapid point of care molecular screening tests that can be easily adapted to emerging pathogens and are selective, sensitive, reliable in different settings around the world.

View Article and Find Full Text PDF